Pathogen recognition receptor (PRR) signaling is critical for triggering innate immune activation and the expression of immune response genes, including genes that impart restriction against 
INTRODUCTION
Interferon regulatory factors (IRFs) are transcription factors (TFs) that play key roles in regulating gene networks that coordinate appropriate and effective immune responses. 1 Originally described as transcriptional regulators of the type I IFN system, IRFs play essential roles in a myriad of processes within innate and adaptive immunity and beyond. 2, 3 Mammals have 9 IRF family members that share a highly conserved N-terminal DNA binding domain and are predicted to regulate genes containing the IRF binding motif defined by the GAAAcontaining nucleotide motif "GAAANNGAAA". 4, 5 resulting in more rapid death when compared to the single gene KO mice. 11, 12 However, DKO mice still produced type I IFN upon WNV infection, indicating that IFN production is regulated by additional factors at least in the absence of IRF3 and IRF7. 13 In addition, cell-type specific usage of specific IRF family members to induce antiviral gene expression has been observed. Ex vivo experiments with primary neurons and fibroblasts indicated that IFN-induction upon WNV infection was abrogated in the absence of IRF3 and IRF7, whereas IFN-production from dendritic cells (DCs) and macrophages after WNV infection was sustained in DKO cells. 14 Additional studies utilizing primary cells from Irf3-/-Irf5-/-Irf7-/-triple KO (TKO) mice indicate that IRF5 is responsible for triggering IFN and the production of other cytokines in DCs in response to WNV infection. 15 However, whether IRF5 plays redundant or distinct roles from IRF3 and IRF7 in regulating antiviral innate immune response in DCs remains unclear.
Multiple studies have shown that IRF5 plays an immune protective role against infection by various viruses. [16] [17] [18] [19] However, in contrast to IRF3 and IRF7, the role of IRF5 in regulating antiviral defenses and viral infection is not well understood though studies of Irf5-/-mice show that IRF5 participates in directing the production of IFNand proinflammatory cytokines in vivo in response to virus infection and other inflammatory stimuli. [20] [21] [22] [23] Moreover, in humans, IRF5 autoimmune risk haplotypes are correlated with elevated levels of IFN-, [24] [25] [26] [27] wherein DCs from these haplotype carriers produce elevated TNF-and IL-12 upon TLR stimulation. 28, 29 Beyond cytokines, IRF5 regulates expression of genes essential for B cell differentiation, activation, and proliferation downstream of TLR9 and B cell receptor signaling. 30, 31 These studies firmly established an important and versatile role of IRF5 in modulating both innate and adaptive immune responses through actions in various cell types. The precise function of IRF5 in regulating immune gene expression in response to virus infection remains to be elucidated.
We performed in-depth genomic analyses to identify bona fide IRF5 primary gene targets in mouse DCs ex vivo. We first assessed IRF5 dependent gene expression by examining global gene expression in WNV-infected bone marrow-derived DCs (BMDCs) from Irf5-/-(IRF5 KO) and wild-type (WT) mice using next-generation RNA sequencing (RNA-seq). We then produced a high resolution genome-wide IRF5 occupancy map of mock-and WNV-infected BMDCs using chromatin immunoprecipitation combined with exonuclease digestion (ChIP-exo) followed by high-throughput sequencing (ChIP-seq). 32 Our data sets identify novel IRF5 binding motifs in additional to the canonical IRF binding motif, and reveal gene loci previously not shown to be regulated by IRF5. Integrative bioinformatics analyses revealed a high confidence IRF5 target gene set. Our study provides the first in-depth genome-wide analysis of IRF5 target genes and gene expression in DCs during acute WNV infection.
MATERIALS AND METHODS

Cells and virus infection
Bone marrow (BM) cells were extracted from femurs of 6-8-wk-old WT B6 and Irf5-/-(corrected for Dock2 mutation) mice. Bone marrowderived dendritic cells (BMDCs) were obtained by culturing BM cells in complete RPMI supplemented with recombinant mouse IL-4 (40 ng/ml, Peprotech, Rocky Hill, NJ) and GM-CSF (40 ng/ml, Peprotech) for 7-9 days, changing media on day 3. Bone marrow-derived macrophages (BMMs) were obtained by culturing BM cells in complete DMEM supplemented with recombinant mouse M-CSF (40 ng/ml, Peprotech) for 7 days, changing media on day 3. Cells were kept at 37 • C with 5% CO 2 .
WNV Texas 2002 strain was propagated using previously described methods. 33 Supernatants collected from infected Vero cells were titered on BHK-21 cells and stored at 80 • C.
For WNV infection, BMDCs or BMMs were infected in serum-free media with 2.5 MOI of WNV for 1.5 h with gentle rocking. Complete media was added back and cells were harvested at the time points indicated. Biologic triplicates were used for all experiments.
RNA extraction for RNAseq analysis
Total RNA was extracted using RNeasy mini kit Qiagen (Hilden, Germany) with on-column DNase treatment. RNA quality was assessed using RNA 6000 nano kit on the 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). BMDC RNA with an RNA integrity number (RIN) of ≥8 was sent to Seattle Genomics (University of Washington, Seattle, WA, USA) for cDNA library construction using the 
ChIP-exo
Chromatin was isolated using a truChIP chromatin shearing kit Covaris (Matthews, NC) and sheared using M220 focused-ultrasonicator (Covaris). Sheared chromatin was run on an agarose gel and band corresponding to size 200-700 bp was extracted. Immunoprecipitation was performed with validated IRF5 antibodies (Bethyl A303-385 and A303-386). Exonuclease processing of sheared chromatin and library construction was performed using ChIP-exo kit (Active Motif).
Library size and quality was assessed using High Sensitivity DNA kit (Agilent) on the 2100 Bioanalyzer (Agilent). Next-generation sequencing was performed on the Illumina HiSeq 2500 instrument by the Genome Technology Access Center (Washington University, St. Louis, MO, USA). Raw reads were submitted to GEO (accession no. GSE114993).
Sequencing and data processing
Quality of both mRNA-seq and ChIP-exo reads were assessed using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and ribosomal sequences were filtered via alignments with Bowtie v2.1.0 (bowtie-bio.sourceforge.net/). Subsequently, mRNA-seq reads were mapped to the UCSC mm10 genome obtained from iGenomes using STAR v2.4.0j (https://github.com/alexdobin/STAR/releases/ tag/STAR_2.4.0j) followed by HTSeq-count v0.6.0 (https://htseq.rea dthedocs.io/en/release_0.10.0/) to generate gene counts. BAM files generated by STAR were also assessed for additional QC metrics using the ChIPexoQual R package. 34 ChIP-exo reads were mapped to the mm10 genome using Bowtie v1.1.1. 38 Peaks were called using GEM v3.1 35 with corresponding input-only reads as controls using a k-mer length range of 6-13 and the parameters "-smooth 3 ″ and "-mrc 20 ″ as suggested by the developers. To assess consistency between replicates following the Encode ChIP-seq guidelines, 36 overlapping peaks between replicates were assessed by irreproducible discovery rate (IDR) with a cutoff of <0.1.
Differential expression analysis
Genes with less than an average of 10 counts across all samples were removed to filter low-expressing genes. Counts were then normalized using edgeR 37 and voom, 38 and outliers were assessed using principal and co-expressed genes were assigned to modules using Ward's clustering. Modules were then functionally annotated with immunerelated canonical pathways using ingenuity pathway analysis (IPA). 40 Bubble plots and volcano plots were created using the ggplot2 (ggplot2.org/) and ggrepel (https://CRAN.R-project.org/package = ggrepel) R packages.
ChIP-exo analysis
Peak distances from transcription start sites (TSSs) as well as nearest genes were extracted from GREAT v3.0.0 41 using the "Basal plus extension" setting searching for proximal (5 kb upstream, 10 kb downstream) and distal (up to 1000 kb) gene regions. All motifs were identified de novo from combining replicate ChIP samples in GEM and filtering for motifs with a hypergeometric P value <0.001.
Direct comparison of motifs was performed using TomTom. 42 Shared and unique ChIP-exo peaks by experimental condition were identified with Venny (http://bioinfogp.cnb.csic.es/tools/venny/index.html).
Enriched pathways of ChIP-exo peaks in each condition were annotated using canonical pathways in IPA. These genes were then functionally annotated for enriched canonical pathways and networks of protein and expression-level interactions were assembled using the network-building tools within IPA.
Public ChIP datasets
Peaks from other ChIP datasets were collected from ChIP-Atlas, a public database of ChIP experiments that have had peaks called using MACS2. 43 MACS2 scores for each peak were extracted from each SRA sample, averaged by cell type, and finally log-transformed prior to visualization.
Online supplemental material
Supplemental Fig. 1 https://irf5genomics.galelab.org.
RESULTS
Loss of IRF5 results in subtle changes in transcriptional response of DCs during WNV infection
To identify IRF5-dependent WNV response genes, we infected BMDCs from WT and Irf5-/-mice and assessed gene expression at 6, 12, Il10ra, which was up-regulated (Supplemental Fig. 2 ). The expression pattern of these genes suggests that IRF5 selectively represses certain immune regulatory genes while activating others, corroborating with previous findings that IRF5 can act as a transcriptional activator and repressor in different contexts. 19 Although the DE genes unique to WT and Irf5-/-cells provide evidence for IRF5 function, it is important to note that their directional changes in expression were often the same between WT and Irf5-/-cells. This indicates that IRF5 is not the only factor regulating these genes, but likely works cooperatively with other TFs such that the loss of IRF5 can be compensated in the context of immune gene induction.
IRF5 binding profiles change upon WNV infection
Because results from gene expression analysis revealed subtle changes in the absence of IRF5, we sought to identify bona fide IRF5 target genes during virus infection with ChIP-seq experiments on endogenous IRF5. We performed nucleotide-resolution ChIP-exo 32 analysis on mock-and WNV-infected WT and Irf5-/-BMDCs at 6 and 12 h postinfection to precisely identify IRF5 occupied loci and binding motifs.
We validated the specificity of the ChIP-competent antibody and ChIP protocol prior to sequencing (Supplemental Fig. 3) , and ensured the quality of the sequencing data by the ChIPexoQual R package prior to peak calling (https://irf5genomics.galelab.org). We used the Genome wide Event finding and Motif discovery software (GEM) to identify peaks and motif sequences, and assessed peaks consistent across replicates compared to input controls for each respective condition (IDR < 0.1). Overall, mock-infected samples contained more IRF5-binding peaks (153 peaks; 93 at 6 h post-infection and 60 at 12 h post-infection) than WNV-infected samples (109 peaks; 67 at 6 h postinfection and 42 at 12 h post-infection) ( Fig. 2A) . This could be due to the highly stochastic nature of virus infection, such that only a small number of peaks passed statistical threshold as high confidence IRF5 binding peaks within each replicate of primary cells. Genes associated with peaks proximal (−5 kb to + 10 kb) and distal (< 1000 kb) from TSSs were then identified using the Genomic Regions Enrichment of F I G U R E 2 IRF5 peak locations. A. Number of IRF5 ChIP-exo peaks between experimental conditions. B. Number of IRF5 ChIP-exo peaks binned by absolute distance to associated TSS's across experimental conditions Annotations Tool (GREAT). 41 Most peaks found were within 5 kb of TSSs in each experimental condition, although the proportion of these peaks dropped from 59% of all peaks to 38% from 6 to 12 h in both mock and WNV infected samples, suggesting that IRF5 may regulate gene expression via mechanisms other than proximal promoter activation (Fig. 2B ).
To identify IRF5-regulated genes, we used GREAT to identify genes associated with ChIP-exo peaks and compared the IRF5-occupied loci between infection state and time points (Fig. 3A) . At 6 h post-infection 24.4% of genes associated with peaks were shared between WNV and mock infections (49 genes in total), whereas at 12 h 17.7% of genes were shared (29 genes in total) (Supplemental Because the number of ChIP-exo peaks from individual replicates was too small for robust motif identification, we combined replicate samples and used GEM with otherwise identical parameters as above to search for de novo IRF5-binding motifs. We identified a de novo "GAAA" motif within peaks of all replicate-combined conditions using (Fig. 3B) . 4, 5 More than 60% of all peaks generated from replicate-combined conditions included a "GAAA" sequence (https://irf5genomics.galelab.org/). These observations also corroborate results from other studies where IRF5 was found to bind "GAAA" half sites, rather than the "GAAANNGAAA" full site as other IRF factors prefer. 44 Another IRF5 ChIP study also identified composite (G)GAAA motifs. 45 We note that this GAAA motif was not identified in the replicate-combined samples using MEME-ChIP or the individual replicates, due to low peak numbers (data not shown). We observed that the profile of de novo binding motifs changed over time, strongly supporting that IRF5 targets different genes over the time course of infection (Fig. 3C) . A common pattern in the identified IRF5 binding motifs is the prevalence of G and C nucleotides (consisting of 71% of motif positions with strong base calls). Although some motifs reappeared between infection states or time points, only the canonical IRF binding motif was present in all conditions, with all but the WNV 12 h samples containing unique motifs. These results suggest that IRF5 not only recognizes the canonical IRF consensus sequence, but also binds other DNA motifs, or forms complexes with other factors that regulate loci harboring these other motifs, as suggested by previous studies. 45 Honing in on the novel enriched motifs bound by IRF5, we queried the JASPAR TF binding profile database 46 for previously identified non-canonical IRF5 binding motifs. We found significant similarity between the "TCTCGCGAGA" motif in the mock-infected 6 h samples with PB0139.1 ("ANCGAGA") via the motif alignment program TomTom (p = 7.57E-03 and p = 1.99E-02, Euclidean distance and SandelinWasserman function). This motif was identified in a universal protein binding microarray study in mice assessing binding patterns of multiple TFs, 47 validating our motif discovery methodology. These DNA occupancy patterns reveal that IRF5 activity and function in regulating gene expression is dynamic through time during WNV infection.
Identification of IRF5 direct targets using a combinatorial approach linking transcriptional responses and DNA occupancy
To define an IRF5 primary target gene set, we combined RNA-seq and ChIP-exo analyses to identify genes that are both DE in WT BMDCs upon WNV infection, and with IRF5 binding within proximity of the loci. We used stringent criteria to filter out lowly expressed genes and only retained genes with high P value among replicates to identify a bona fide set of IRF5 target genes with high confidence. In total, 12 genes fit the criteria of being bound by IRF5 in their promoter region while being DE in WT DCs upon WNV infection. Within this gene set, several genes have known functions in the immune system, such as
Fcgr4 that encodes an Fc receptor for IgG and IgE antibodies, Herc6
that encodes an E3 ubiquitin ligase for ISGylation, Clic4 that encodes an ion channel shown to regulate IL-1 expression and NLRP3 activation, Ccl2 that encodes a chemokine, and Oasl1 that negatively regulates IFN response but enhances RIG-I signaling response (Table 1) .
Altogether, these 12 primary target genes showed the largest differences in expression at the 6 and 12 h post-infection time points (Fig. 4A ), but were mostly similar by 24 h post-infection (Supplemental Fig. 5 ), suggesting that loss of IRF5 resulted in early dysregulation of gene expression that can be compensated at later time points by other factors.
To identify genes and pathways associated with IRF5 targets, we built an interaction network in IPA with the 12 IRF5 target genes identified in BMDCs. Genes in this IRF5-regulated network included innate immune signaling factors such as DHX58, ISG20, OASL1, OASL2, IFIT3, and IRF7 among others. Based on differences in expression levels of WT and Irf5-/-cells, Fcgr4, and C130026I21Rik are predicted to be activated by IRF5, whereas Ccl2 is predicted to be suppressed. (Fig. 5B and C) . We further assessed expression of genes associated with antiviral response. We observed dependence on IRF5 in Ifnb and Ifit1 genes even though no evidence of IRF5 binding was found at these loci, indicating that IRF5 modulates expression of additional genes related to antiviral response beyond its primary target genes through secondary/indirect mechanisms (Fig. 5D ). We measured WNV genome copy number in WT and Irf5-/-cells to ensure that the gene expression differences observed were not due to substantial differences in WNV infection rate (Fig. 5E) . We note that because of biologic variability of primary DC cultures and the limits of qRT-PCR assays, the changes in gene expression are not all statistically significant based on stringent unpaired t test using biologic triplicates, but the trends are very consistent with RNA-seq results. Overall, these data imply that IRF5 regulates a specific subset of primary target genes, as well as other genes via other means to modulate and fine-tune an antiviral response.
In the case of
IRF5 regulates overlapping and distinct target gene sets in different cell types
To assess whether IRF5 regulates similar set of genes in other cell types, we performed RNA-seq experiment in WT and Irf5-/-WNVinfected BMMs. Globally, BMMs had a more rapid and robust response to WNV infection than BMDCs. The two cell types showed largely [82] [83] [84] [85] overlapping DE gene expression patterns upon WNV infection with fine differences (Fig. 6A) . Focusing on the 12 IRF5 primary target genes identified in BMDCs at early infection time points where differences in WT and Irf5-/-cells are clearest, 8 were also DE in BMMs. Specifically, Oasl1, Fcgr4, Herc6, and Aida showed similar expression patterns between BMDCs and BMMs, whereas Acer3, Frmd4a, and Ccl2 were divergent between the different cell types (Fig. 6B) . Overall, most but not all of these genes showed similar DE pattern between WT and
TA B L E 1 List of IRF5-dependent genes, and their known/predicted functions
Irf5-/-cells within each cell type, indicating that IRF5 likely regulates overlapping and distinct gene targets in different cell types.
IRF family members regulate unique gene sets
IRF family members share the same consensus DNA binding motif. To assess whether IRF5 primary target genes are also regulated by other IRF family members, we examined binding scores from publicly available ChIP experimental data in human and mouse samples aggregated by IRF and cell type (Fig. 7 , Supplemental Table 1 ). Genes such as Aida, Herc6, Acer3, Clic4, and Oasl1 showed evidence of binding consistently across multiple IRFs and cell types, whereas some other genes have a more specific binding profile (e.g., Fcgr4 and Tsku). This suggests that despite sharing a consensus binding motif, each IRF member regulates different sets of genes in a cell type specific context.
DISCUSSION
In this study, we combined two orthogonal approaches to identify bona fide IRF5 primary target genes in BMDCs during WNV infection. Our study is the first to our knowledge to utilize the high-resolution ChIP-exo method to map genome-wide IRF5 occupancy, which allowed us to identify IRF5 binding motifs in near nucleotide resolution and high confidence. In addition to the canonical IRF binding motif, we also identified additional IRF5 binding sites, some uniquely found in virus infection conditions. Compared with other traditional IRF5 ChIPseq studies, 30, 45 we identified lower number of peaks, likely due to the highly specific ChIP-exo protocol and statistical analyses for peak calling. We performed extensive quality control measures to ensure that background is negligible (IgG ChIP yielded no peak) and the ChIP reaction was specific (antibody did not IP any protein of mass corresponding to IRF5 in Irf5-/-cells) (Supplemental Fig. 3 ). The IRF5-bound genetic loci change over the time course of infection, highlighting the dynamic nature of IRF5-regulated genes. We found that IRF5-occupied gene loci during infection corresponded to multiple immune pathways, including DC maturation and NFAT pathways. Combining the RNAseq and ChIP-seq datasets, we honed in on a novel subset of genes that we defined as IRF5 primary target genes with high confidence.
We compared this gene set with DE genes found in macrophages upon WNV infection, and found that some but not all genes showed simi- and long-lived plasma cells were found in Irf5-/-mice. 16 These observations and our data suggest that instead of being the master regulator of a specific immune pathway, IRF5 is rather a key factor that shapes and fine-tunes the antiviral immune response in a manner that is more nuanced and intricate, which impacts the spread of virus infection, mediated optimal innate immune regulation and the regulation of adaptive immunity.
Few studies have combined RNA-seq and ChIP-seq analyses to identify the dynamic immune response genes during virus infection.
IRF5, in particular, is under-studied compared to other IRF family members, partly due to the limited availability of reliable reagents. 56 We carefully tested reagents and developed protocols that allowed us to interrogate endogenous IRF5 in primary cells during WNV infection. 
